Geode Capital Management’s Tiziana Life Sciences TLSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$91.5K Hold
78,204
﹤0.01% 4157
2025
Q4
$117K Hold
78,204
﹤0.01% 4055
2025
Q3
$169K Hold
78,204
﹤0.01% 3979
2025
Q2
$124K Buy
78,204
+319
+0.4% +$426 ﹤0.01% 4011
2025
Q1
$84.1K Sell
77,885
-167,837
-68% -$164K ﹤0.01% 4077
2024
Q4
$171K Buy
245,722
+27,041
+12% +$25K ﹤0.01% 3954
2024
Q3
$210K Sell
218,681
-840
-0.4% -$848 ﹤0.01% 3885
2024
Q2
$202K Buy
219,521
+3,696
+2% +$2.7K ﹤0.01% 3906
2024
Q1
$93K Buy
215,825
+4,658
+2% +$2.44K ﹤0.01% 4180
2023
Q4
$118K Buy
211,167
+4,751
+2% +$3K ﹤0.01% 4132
2023
Q3
$139K Buy
206,416
+4,453
+2% +$3.07K ﹤0.01% 4130
2023
Q2
$138K Buy
201,963
+1,501
+0.7% +$1.27K ﹤0.01% 4212
2023
Q1
$221K Buy
200,462
+3,476
+2% +$2.27K ﹤0.01% 3998
2022
Q4
$119K Buy
196,986
+2,370
+1% +$1.57K ﹤0.01% 4332
2022
Q3
$151K Buy
194,616
+6,399
+3% +$4.82K ﹤0.01% 4360
2022
Q2
$140K Buy
188,217
+2,528
+1% +$2.17K ﹤0.01% 4440
2022
Q1
$194K Buy
185,689
+43,797
+31% +$38.8K ﹤0.01% 4400
2021
Q4
$136K Buy
141,892
+8,021
+6% +$10.6K ﹤0.01% 4624
2021
Q3
$195K Buy
133,871
+49,290
+58% +$91K ﹤0.01% 4459
2021
Q2
$198K Buy
84,581
+69,729
+469% +$172K ﹤0.01% 4346
2021
Q1
$41K Buy
+14,852
New +$49.3K ﹤0.01% 4419

Other funds holding TLSA

Geode Capital Management's TLSA Position: Q1 2026 in Review

Geode Capital Management held its Tiziana Life Sciences (TLSA) position steady in Q1 2026 at 78,204 shares worth $91.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4157.

Geode Capital Management first reported a position in TLSA in Q1 2021 and has held it in 21 quarters since. The position peaked at $221K in Q1 2023. 32 funds tracked by Wall St. Rank hold TLSA as of Q1 2026.

  • Geode Capital Management held 78,204 shares of Tiziana Life Sciences worth $91.5K as of Q1 2026.
  • Geode Capital Management left its Tiziana Life Sciences share count unchanged in Q1 2026.
  • Tiziana Life Sciences made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4157 holding.
  • Geode Capital Management first reported a position in Tiziana Life Sciences in Q1 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Tiziana Life Sciences position peaked at $221K in Q1 2023.
  • 32 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.